EPIM
INDV icon

Evelyn Partners Investment Management’s Indivior Pharmaceuticals INDV Stock Holding History

Evelyn Partners Investment Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$415K Buy
13,624
+981
+8% +$32.4K 0.01% 167
2025
Q4 		$454K Hold
12,643
– – 0.01% 164
2025
Q3 		$305K Buy
12,643
+459
+4% +$9.61K 0.01% 178
2025
Q2 		$180K Sell
12,184
-1,497
-11% -$17.4K 0.01% 205
2025
Q1 		$130K Buy
13,681
+419
+3% +$4.41K ﹤0.01% 222
2024
Q4 		$165K Buy
+13,262
New +$136K 0.01% 204

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Evelyn Partners Investment Management's INDV Position: Q1 2026 in Review

Evelyn Partners Investment Management increased its Indivior Pharmaceuticals (INDV) stake by 7.8% in Q1 2026, buying an estimated $32.4K and bringing the position to 13,624 shares worth $415K. The position accounts for 0.01% of the portfolio, ranked #167.

Evelyn Partners Investment Management first reported a position in INDV in Q4 2024 and has held it in 6 quarters since. The position peaked at $454K in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Evelyn Partners Investment Management held 13,624 shares of Indivior Pharmaceuticals worth $415K as of Q1 2026.
  • Evelyn Partners Investment Management bought 981 Indivior Pharmaceuticals shares in Q1 2026, an estimated $32.4K.
  • Indivior Pharmaceuticals made up 0.01% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #167 holding.
  • Evelyn Partners Investment Management first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management's Indivior Pharmaceuticals position peaked at $454K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.